Synbiotic supplementations for Azotemia in patients with chronic kidney disease: A randomized controlled trial

Iranian Journal of Kidney Diseases

Volumn 10, Issue 6, 2016, Pages 351-357

  Dehghani, Hamideh ^a   Heidari, Fatemeh ^a   Mozaffari Khosravi, Hassan ^b   Nouri Majelan, Nader ^a   Dehghani, Ali ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GERASH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Azotemia; Chronic kidney disease; Kidney function; Synbiotic supplements

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; PLACEBO; SYNBIOTIC AGENT; CREATININE; PREBIOTIC AGENT; PROBIOTIC AGENT; URIC ACID;

ADULT; AGE; AGED; ARTICLE; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BODY MASS; CHRONIC KIDNEY DISEASE; COLORIMETRY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS THERMOPHILUS; UREA NITROGEN BLOOD LEVEL; UREMIA; URIC ACID BLOOD LEVEL; AZOTEMIA; BLOOD; COMPLICATION; DIETARY SUPPLEMENT; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX;

AGED; AZOTEMIA; BLOOD UREA NITROGEN; CREATININE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PREBIOTICS; PROBIOTICS; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; SYNBIOTICS; URIC ACID;

EID: 85003520704     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Smeltzer SC, Bare BG, Hinklek JL, Cheever KH. Brunner and Suddarth’s textbook of medical surgical nursing: in one volume. 11th ed. Lippincott Williams & Wilkin; 2008. p. 1311-46.
2. Najafi I, Shakeri R. Prevalence of chronic kidney disease and its associated risk factors: the first report from Iran using both microalbuminuria and urine sediment. Arch Iran Med. 2012;15:70-5.
3. Ranganathan N, Patel B, Ranganathan P, et al. Probiotic amelioration of azotemia in 5/6th nephrectomized Sprague-Dawley rats. Sci World J. 2005;5:652-60.
4. Khalkhali H, Hajizadeh E, Kazemnejad A, Ghafari M. The prediction’s trend of graft survival in renal transplantation with chronic allograft dysfunction. Iran J Epidemiol. 2010;6:25-31.
5. Jain P, Shah S, Coussa R, Prakash S. Potentials and limitations of microorganisms as renal failure biotherapeutics. Biologics. 2009;3:233-43.
6. Safarinejad MR. The epidemiology of adult chronic kidney disease in a population-based study in Iran: Prevalence and associated risk factors. J Nephrol. 2009;22:99-108.
7. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl J Med. 2004;351:1296-305.
8. Weir MR. Recognizing the link between chronic kidney disease and cardiovascular disease. Am J Manag Care. 2011;17:S396-402.
9. Barsoum RS. Chronic kidney disease in the developing world. New England Journal of Medicine. 2006;354:997-99.
10. Mitch WE, Maroni BJ. Nutritional considerations and the indications for dialysis. Am J Kidney Dis. 1998;31:185-89.
11. Vendrely B, Chauveau P, Barthe N, et al, Nutrition in hemodialysis patients previously on a supplemented very low protein diet. Kidney Int. 2003;63:1491-98.
12. Din Mohammadi MR, Poor Memari MH. Evaluation of some nutritional parameters in hemodialysis patients referred to Shahid Beheshti Hospital dialysis center in Zanjan. J Zanjan Univ Med Sci. 2002;10:41-5.
13. Takayama F, Taki K, Niwa T. Bifidobacterium in gastroresistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis. Am J Kidney Dis. 2003;41:S142-5.
14. Bossola M, Muscaritoli M, Tazza L, et al. Malnutrition in hemodialysis patients: What therapy? Am J Kidney Dis. 2005;46:371-86.
15. Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotics: A review. J Am Diabetes Assoc. 2001;101:229-41.
16. Vojdani R, Zali MR. Probiotics and their mechanism in the prevention and treatment of human diseases. Med Res. 2003;27:319-30.
17. Jacobi CA, Schulz C, Malfertheiner P. Treating critically ill patients with probiotics: Beneficial or dangerous? Gut Pathogens. 2011;3:1-5.
18. Drakoularakou A, Rastall R, Gibson G, Saarela M. Functional foods for the gut: Probiotics, prebiotics and synbiotics. Functional foods: concept to product. 205 ed. Philadelphia: Woodhead Publishing; 2011;449-70.
19. Ranganathan N, Ranganathan P, Friedman EA, et al. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther. 2010;27:634-47.
20. Solga S. Probiotics can treat hepatic encephalopathy. Med Hypotheses. 2003;61:307-13.
21. Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Applied Microbiol. 2006;100:1171-85.
22. Ötles S, Çag nd Ö, Akçiçek E. Probiotics and health. Asian Pacific J Cancer Prev. 2003;4:369-72.
23. Fabian E, Majchrzak D, Dieminger B, Meyer E, Elmadfa I. Influence of probiotic and conventional yoghurt on the status of vitamins B1,B2 and B6 in young healthy women. Ann Nutr Metab. 2008;52:29-36.
24. Alavi Naini AM, Ghandchi Z, Sepandi M, Taghdir M, Ashourpour M, Pourghaderi M. Assessment of vitamin and mineral intake and some related factors in hemodialysis patients referred to Imam Khomeini Hospital, Tehran. Iran J Endocrinol Metab. 2012;13:607-13.
25. Abboud H, Henrich WL. Stage IV chronic kidney disease. New Eng J Med. 2010;362:56-65.
26. Ejtahed H, Mohtadi Nia J, Homayouni Rad A, Niafar M, Asghari Jafarabadi M, Mofid V. The effects of probiotic yoghurt consumption on blood pressure and serum lipids in type 2 diabetic patients: Randomized clinical trial. Iran J Nutr Sci Food Technol. 2012;6:1-12.
27. Ejtahed H, Mohtadi Nia J, Homayouni Rad A, Niafar M, Asghari Jafarabadi M, Mofid V. The effects of probiotic and conventional yoghurt on diabetes markers and insulin resistance in type 2 diabetic patients: A randomized controlled clinical trial. Iran J Endocrinol Metab. 2011;13:1-8.
28. Ranganathan N, Friedman EA, Tam P, Rao V, Ranganathan P, Dheer R. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: A 6-month pilot scale trial in Canada. Curr Med Res Opin. 2009;25:1919-30.
29. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441-49.
30. Patel B, Zelenaia O, Dheer R. Oral bacteriotherapy effectively reduces severity of azotemia in 5/6th nephrectomized rats. J Am Soc Nephrol. 2003;14:765A.
31. Ranganathan N, Patel B, Ranganathan P, et al. Probiotics reduce azotemia in Gottingen minipigs. 3rd World Congress of Nephrology. Singapore; 2005.
32. Prakash S, Chang T. In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells. Int J Artif Organ. 2000;23:429.
33. Friedman EA. Can the bowel substitute for the kidney in advanced renal failure? Curr Med Res Opin. 2009; 25:1913-18
34. Ranganathan N, Patel BG, Ranganathan P, et al. In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease. ASAIO J. 2006;52:70-9.
35. Rathi M, Sahni N, Kohli H, Jha V, Sakhuja V. Effect of probiotic-prebiotic supplementation with diet counseling in chronic kidney disease. Kidney Res Clin Pract. 2012;31:A67.
36. Azadbakht L, Atabak S, Zahedi M, Tehrani M, Esmaillzadeh A. Soy protein intake, cardiovascular risks, CRP-level and kidney function among type 2 diabetic patients with nephropathy. Zahedan J Res Med Sci. 2012;14:31-8.
37. Di Cerbo A, Pezzuto F, Palmieri L, Rottigni V, Iannitti T, Palmieri B. Clinical and experimental use of probiotic formulations for management of end-stage renal disease: An update. Int Urol Nephrol. 2013;45:1569-76.
38. Zou C, Lu ZY, Wu YC, et al. Colon may provide new therapeutic targets for treatment of chronic kidney disease with Chinese medicine. Chinese J Integrat Med. 2013;19:86-91.
39. Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein intype 2 diabetes with nephropathy a longitudinal randomized clinical trial. Diabetes Care. 2008;31:648-54.